A federal Crown corporation paid more than $330,000 to an outside marketing firm to rebrand a planned passenger rail project between Toronto and Quebec City.

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.